Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Jarushka Naidoo, MBBCh, Sidney Kimmel Cancer Center, Johns Hopkins
home
Articles
Updates on I/O Therapy for Non-Driver mNSCLC
September 1st 2020
EGFR Exon 20 Mutations in NSCLC
September 1st 2020
KRAS-Mutant NSCLC
September 1st 2020
HER2 Targeted Therapy for Treatment of NSCLC
September 1st 2020
MET Exon 14 Mutations in mNSCLC
September 1st 2020
RET Fusion+ mNSCLC
September 1st 2020
Educational Tools for Possible Drug-Induced ILD
June 30th 2020
Management of Patients Who Develop ILD
June 30th 2020
Changes in Treatment Goals due to Drug Induced ILD
June 30th 2020
Risk of ILD as a Class Effect and Identifying ILD
June 30th 2020
Risks for Developing ILD in Gastrointestinal Cancer Studies
June 30th 2020
Role of Antibody Drug Conjugates and Personal Experience
June 30th 2020
Patient Management and Educational Tools for ILD
June 30th 2020
Identifying Drug-Induced ILD
June 30th 2020
Rate of ILD and Monitoring Parameters
June 30th 2020
Personal Experience with Drug-Induced ILD
June 30th 2020
Potential Risk of Drug-Induced Interstitial Lung Disease
June 30th 2020
Patient Management upon Developing ILD and Education
June 30th 2020
Patient Factors for Developing ILD and Personal Experience
June 30th 2020
Drug-Induced ILD and Rate of Occurrence in GI Cancer Trials
June 30th 2020
NEXT PAGE
<
1
2
>
PREVIOUS PAGE